Parkside Financial Bank & Trust raised its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 3.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,673 shares of the company’s stock after purchasing an additional 194 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Colgate-Palmolive were worth $607,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Centricity Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Bernard Wealth Management Corp. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $43,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
CL has been the subject of a number of research analyst reports. Piper Sandler decreased their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Finally, Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $91.27 on Friday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The business has a fifty day moving average price of $88.74 and a 200-day moving average price of $95.51. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market capitalization of $74.07 billion, a P/E ratio of 25.93, a PEG ratio of 4.20 and a beta of 0.44.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business earned $0.87 earnings per share. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Airline Stocks – Top Airline Stocks to Buy Now
- 5 Best Gold ETFs for March to Curb Recession Fears
- The 3 Best Retail Stocks to Shop for in August
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.